{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:31:19Z","timestamp":1787729479816,"version":"build-2784847793"},"reference-count":56,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2012,5,31]],"date-time":"2012-05-31T00:00:00Z","timestamp":1338422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2012,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The use of prothrombin complex concentrates (PCCs), a heterogeneous combination of coagulation factors and counterbalancing inhibitor components, has broadened in recent years beyond single\u2010factor replacement in conditions such as hemophilia B, to encompass emergency reversal of anticoagulation secondary to oral vitamin K antagonists, ie, warfarin therapy. PCCs also have been studied in other bleeding disorders, such as surgery\u2010related and trauma\u2010related bleeding. This review provides an updated examination of the differences among PCC formulations, their potential role in the management of bleeding disorders, and the primary safety issues affecting their use. Am. J. Hematol. 2012. \u00a9 2012 Wiley Periodicals, Inc.<\/jats:p>","DOI":"10.1002\/ajh.23254","type":"journal-article","created":{"date-parts":[[2012,5,7]],"date-time":"2012-05-07T05:07:19Z","timestamp":1336367239000},"page":"898-902","source":"Crossref","is-referenced-by-count":30,"title":["Prothrombin complex concentrates in emergency bleeding disorders"],"prefix":"10.1002","volume":"87","author":[{"given":"George M.","family":"Rodgers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,5,31]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0265021508004675"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61199-4"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.1412S3"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc9311"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2008.01859.x"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-009-0412-5"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.02904.x"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-009-9310-0"},{"key":"e_1_2_7_10_2","volume-title":"Feiba NF (anti\u2010inhibitor coagulant complex) [package insert]","author":"Baxter Health Care Corp","year":"2011"},{"key":"e_1_2_7_11_2","first-page":"117","article-title":"Three or four factor prothrombin complex concentrate for emergency anticoagulation reversal?","volume":"9","author":"Makris M","year":"2011","journal-title":"Blood Transfus"},{"key":"e_1_2_7_12_2","volume-title":"Bebulin VH [package insert]","author":"Baxter Healthcare Corp","year":"2001"},{"key":"e_1_2_7_13_2","volume-title":"Beriplex P\/N (human prothrombin complex) [product monograph]","author":"CSL Behring Canada","year":"2010"},{"key":"e_1_2_7_14_2","volume-title":"Cofact [package insert]","author":"Sanquin","year":"2006"},{"key":"e_1_2_7_15_2","unstructured":"Kaskadil [prescribing information]. Available at:http:\/\/www.doctissimo.fr\/medicament\u2010KASKADIL.htm. Accessed on January 4 2012."},{"key":"e_1_2_7_16_2","volume-title":"Octaplex [prescribing information]","author":"Octapharma","year":"2008"},{"key":"e_1_2_7_17_2","volume-title":"Profilnine SD [package insert]","author":"Grifols","year":"2004"},{"key":"e_1_2_7_18_2","volume-title":"Proplex T [package insert]","author":"Baxter Healthcare Corp","year":"2002"},{"key":"e_1_2_7_19_2","volume-title":"Prothrombinex\u2010VF [package insert]","author":"CSL Limited","year":"2011"},{"key":"e_1_2_7_20_2","volume-title":"Uman Complex [package insert]","author":"Kedrion S.p.A","year":"2002"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0b013e3181ec611b"},{"key":"e_1_2_7_22_2","unstructured":"National Advisory Committee on Blood and Blood Products. Recommendations for use of Octaplex\u00ae in Canada. Available at:http:\/\/www.gov.ns.ca\/health\/nspbcp\/docs\/NAC%20octaplex%20recommendations.pdf. September 16 2008. Accessed on October 27 2011."},{"key":"e_1_2_7_23_2","unstructured":"Canadian Blood Services. Availability of Beriplex\u00ae P\/N (Human prothrombin complex). Available at:http:\/\/www.blood.ca\/CentreApps\/Internet\/UW_V502_ MainEngine.nsf\/resources\/CustomerLetters2011\/$file\/CL2011\u201020.pdf. August 2 2011. Accessed on December 8 2011."},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-009-9250-3"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(08)70004-5"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-009-0830-7"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.1_suppl.8S"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0b013e3282010d7a"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0007-1048.2001.03295.x"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2005.08.005"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-007-0528-z"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2007.02.009"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01815.x"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2006.tb00277.x"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2010.02237.x"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.23.7.972"},{"key":"e_1_2_7_37_2","first-page":"148","article-title":"Emergency reversal of anticoagulation with a three\u2010factor prothrombin complex concentrate in patients with intracranial haemorrhage","volume":"9","author":"Imberti D","year":"2011","journal-title":"Blood Transfus"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1159\/000321766"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21046"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1Q096"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1655992"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2010.01339.x"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000221786.81354.d6"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2011.01.011"},{"key":"e_1_2_7_45_2","volume-title":"Pradaxa\u00ae (dabigatran etexilate mesylate) [package insert]","author":"Boehringer Ingelheim Pharmaceuticals, Inc","year":"2011"},{"key":"e_1_2_7_46_2","volume-title":"Xarelto\u00ae (rivaroxaban) [package insert]","author":"Janssen Pharmaceuticals, Inc","year":"2011"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-09-241851"},{"key":"e_1_2_7_48_2","first-page":"68","article-title":"Bleeding in patients using new anticoagulants or antiplatelet agents: Risk factors and management","volume":"68","author":"Levi MM","year":"2010","journal-title":"Neth J Med"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.029017"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc8186"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2011.01478.x"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P605"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200301000-00004"},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aer140"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2004.03.004"},{"key":"e_1_2_7_56_2","first-page":"149","article-title":"Prothrombin complex concentrates: An update","volume":"8","author":"Franchini M","year":"2010","journal-title":"Blood Transfus"},{"key":"e_1_2_7_57_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH11-01-0052"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.23254","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.23254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T21:21:43Z","timestamp":1696972903000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.23254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,31]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["10.1002\/ajh.23254"],"URL":"https:\/\/doi.org\/10.1002\/ajh.23254","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,31]]}}}